Delta Presents Comprehensive Solutions for AI Data Center with Containerized Data Center & HVDC Power Solution at COMPUTEX 2025
TAIPEI, May 21, 2025 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, today unveiled its comprehensive solutions for the AI era with a focus on sustainability under the theme "Artificial Intelligence x Greening...
Avance Clinical Honored with Frost & Sullivan's 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
This award recognizes Avance Clinical's strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials. SAN ANTONIO, May 14, 2025 /PRNewswire/ -- Frost & Sullivan has named Avance Clinical...
INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness
Global antiviral R&D is slowing when the world can least afford it, new analysis shows CAMBRIDGE, Mass., May 6, 2025 /PRNewswire/ -- The INTREPID Alliance today released the fourth edition of its Antiviral Clinical and Preclinical Development...
MINISO Releases 2024 ESG Report Highlighting its Position as an Industry Leader
GUANGZHOU, China, April 30, 2025 /PRNewswire/ -- Global lifestyle brand MINISO recently released its 2024 ESG (Environment, Society and Governance) Report, which underscores how the brand is contributing to brighter futures across many aspects -...
Antengene Presents Four Posters at AACR 2025 Highlighting Focuses on AnTenGagerTM TCEs and Synthetic Lethality
SHANGHAI and HONG KONG, April 26, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing...
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
- Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles - - New data on MM-II to be presented this weekend at the OARSI 2025 World Conference on Osteoarthritis - -...
ASEAN+3 Positioned for Resilience Amid Unprecedented Trade Shocks
SINGAPORE, April 21, 2025 /PRNewswire/ -- The ASEAN+3 Macroeconomic Research Office (AMRO) today released its annual flagship report, the ASEAN+3 Regional Economic Outlook (AREO) 2025, highlighting the region's resilience and policy capacity to...
Global Times: Practitioners' Insights: A light rail in Hanoi weaves China-Vietnam cordiality, highlighting commitment to pursuing friendship with neighbors
BEIJING, April 21, 2025 /PRNewswire/ -- "At present, China's relations with its neighboring countries are at their best in modern times, and are also entering a critical phase of deep linkage between the regional landscape and the world changes" –...
Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025
CBL-514, Caliway's novel small molecule drug, was selected for data presentation at the World Orphan Drug Congress USA 2025, highlighting its promising Phase 2 study results (CBL-0201DD) for Dercum's Disease Treatment. The Phase 2 topline results...
2025 IBM X-Force Threat Index: Large-Scale Credential Theft Escalates, Threat Actors Pivot to Stealthier Tactics
Nearly half of all cyberattacks resulted in stolen data or credentials Identity abuse was the preferred entry point Asia Pacific represented more than one-third of attacks in 2024 ARMONK, N.Y., April 17, 2025 /PRNewswire/ -- IBM (NYSE: IBM) today...